Cargando…
A Retrospective Cross-Sectional Cohort Trial Assessing the Prevalence of MTHFR Polymorphisms and the Influence of Diet on Platinum Resistance in Ovarian Cancer Patients
SIMPLE SUMMARY: Ovarian cancer (EOC) has a very poor prognosis, with a 5-year survival rate of just 43%. One of the biggest challenges is the resistance to standard chemotherapeutics. Nutrition modification is a potential adjunct that may be suitable to support cancer therapies through epigenetic mo...
Autores principales: | Phillips-Chavez, Caitlin, Coward, Jermaine, Watson, Michael, Schloss, Janet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533864/ https://www.ncbi.nlm.nih.gov/pubmed/34680361 http://dx.doi.org/10.3390/cancers13205215 |
Ejemplares similares
-
Variations in folate prescriptions for patients with the MTHFR genetic polymorphisms: A case series study
por: Ledowsky, Carolyn Jane, et al.
Publicado: (2023) -
New perspectives on targeted therapy in ovarian cancer
por: Coward, Jermaine IG, et al.
Publicado: (2015) -
Polymorphisms in TS, MTHFR and ERCC1 genes as predictive markers in first-line platinum and pemetrexed therapy in NSCLC patients
por: Krawczyk, Paweł, et al.
Publicado: (2014) -
MTHFR polymorphisms in childhood acute lymphoblastic leukemia: influence on methotrexate therapy
por: Umerez, Maitane, et al.
Publicado: (2017) -
MTHFR polymorphisms and breast cancer risk
por: Hosseini, Mojgan, et al.
Publicado: (2011)